Nkgen Biotech Inc. · OTC:NKGN

PATHSTONE FAMILY OFFICE, LLC reported a 7.91% stake in Nkgen Biotech Inc. (Schedule 13G)

Event Oct 17, 2024 · Filed Feb 28, 2025

PATHSTONE FAMILY OFFICE, LLC reported a 7.91% stake in Nkgen Biotech Inc., 2,797,661 shares, as a passive investor on Oct 17, 2024. Filed Feb 28, 2025 (Schedule 13G).

Stake
7.91%
Shares
2,797,661
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
PATHSTONE FAMILY OFFICE, LLC7.91%2,797,661

Source

View original at SEC

Related